MoneyWorks4Me

The sales for the September 2021 quarter moved down -31.01% to Rs. 3304.00 millions as compared to Rs. 4789.00 millions during the year ago period.The Company's Net profit for the September 2021 quarter have declined marginally to Rs. 536.00  millions as against Rs. 709.00 millions reported during the corresponding quarter ended.The company reported a degrowth in operating Profit to 897.00 millions from 1176.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 3304.00 4789.00 -31.01 7242.00 10111.00 -28.38 16535.00 17902.00 -7.64
Other Income 403.00 272.00 48.16 526.00 471.00 11.68 1011.00 1238.00 -18.34
PBIDT 897.00 1176.00 -23.72 2156.00 3101.00 -30.47 5187.00 7018.00 -26.09
Interest 32.00 27.00 18.52 50.00 60.00 -16.67 113.00 206.00 -45.15
PBDT 865.00 1149.00 -24.72 2106.00 3041.00 -30.75 5074.00 6812.00 -25.51
Depreciation 342.00 284.00 20.42 673.00 560.00 20.18 1152.00 981.00 17.43
PBT 523.00 865.00 -39.54 1433.00 2481.00 -42.24 3922.00 5831.00 -32.74
TAX -13.00 156.00 -108.33 145.00 505.00 -71.29 827.00 1086.00 -23.85
Deferred Tax -113.00 -50.00 126.00 -110.00 -115.00 -4.35 -106.00 -205.00 -48.29
PAT 536.00 709.00 -24.40 1288.00 1976.00 -34.82 3095.00 4745.00 -34.77
Equity 365.00 364.00 0.27 365.00 364.00 0.27 365.00 364.00 0.27
PBIDTM(%) 27.15 24.56 10.56 29.77 30.67 -2.93 31.37 39.20 -19.98
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..